share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

SEC announcement ·  Apr 27 01:28
Summary by Futu AI
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.